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Abstract
Background: Different populations have diverse patterns of relationships between Impaired Fasting Glucose (IFG)
and obesity and lipid markers, it is important to investigate the characteristics of associations between IFG and
other related risk factors including body mass index (BMI), waist circumstance (WC), serum lipids and blood
pressure (BP) in a Chinese population.
Methods: This was a case-control study of 648 IFG subjects and 1,296 controls derived from a large-scale,
community-based, cross-sectional survey of 10,867 participants. Each subject received a face-to-face interview,
physical examination, and blood tests, including fasting blood glucose and lipids. Student’s t-test, Chi-square test,
Spearman correlation and multiple logistic regressions were used for the statistical analyses.
Results: Fasting plasma glucose (FPG) was positively correlated with BMI, WC, systolic blood pressure (SBP),
diastolic blood pressure (DBP), triglyceride (TG), and total cholesterol (TC), and was negatively correlated with high
density lipoprotein-cholesterol (HDL-C) (all p < 0.05). BMI was more strongly correlated with IFG than with WC. The
correlation coefficient of FPG was remarkably higher with TG (0.244) than with TC (0.134) and HDL-C (-0.192). TG
was an important predictor of IFG, with odds ratios of 1.76 (95%CI: 1.31-2.36) for subjects with borderline high TG
level (1.70 mmol/l ≤ TG < 2.26 mmol/l) and 3.13 (95% CI: 2.50-3.91) for those with higher TG level (TG ≥ 2.26
mmol/l), when comparing to subjects with TG < 1.70 mmol/l. There was a significant dose-response relationship
between the number of abnormal variables and increased risk of IFG.
Conclusions: In this Chinese population, both BMI and WC were important predictors of IFG. Abnormal TG as a
lipid marker was more strongly associated with IFG than were TC and HDL-C. These factors should be taken into
consideration simultaneously for prevention of IFG.
Background
Impaired fasting glucose (IFG) is a frequent glycemic
disorder in the general population and is considered as
a pre-diabetic state [1]. IFG has received increasing
attention in recent years, not only because it is an inter-
mediate stage in the development of diabetes and cardi-
ovascular diseases (CVDs) [2-4], but also because it is
associated with increased risk of all-cause death and
CVD mortality [5]. IFG has thus come to be considered
as a potential indicator of preventive importance for dia-
betes and CVDs [6].
IFG was first introduced as a concept by the American
Diabetes Association (ADA) in 1997 and was defined as
the presence of abnormal fasting plasma glucose (FPG ≥
6.1 mmol/l and < 7.0 mmol/l) [7]. Nevertheless, in the
l i g h to fe v i d e n c ef r o ms e v e r al epidemiological studies,
the ADA lowered the threshold for diagnosis of IFG to
FPG ≥ 5.6 mmol/l, with the expectation that progression
of pre-diabetes into diabetes and the development of
CVD can be prevented through earlier awareness and
intervention [8]. IFG occurs frequently in Chinese popu-
lations, with a prevalence of 21.6% among adults age 35-
64 years [9], as defined by the new criterion of ≥ 5.6
mmol/l and < 7.0 mmol/l [8].
In addition to IFG, other common risk factors asso-
ciated with diabetes and CVD, such as obesity and
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non-communicable diseases. Because different popula-
tions have diverse patterns of relationships between IFG
and obesity and lipid markers, it is important to investi-
gate the characteristics of associations between IFG and
other related risk factors in the Chinese population. In
addition, because IFG is the early stage of diabetes and
cardiovascular diseases, identifying preventable risk fac-
tors associated with IFG at this early stage is very
important in prevention and control of these diseases.
Therefore, in this study we present the relationships
between IFG and obesity and lipid markers ascertained
in a community-based case-control study of IFG in
Wuxi city, south Jiangsu Province, China.
Methods
This study was approved by the ethnic committee of
the Institute of Geriatrics of Beijing Hospital, Ministry
of Health of China. The case-control study of IFG was
derived from a large-scale, community-based, cross-
sectional survey of non-communicable diseases con-
ducted in the Wuxi municipality, Jiangsu Province of
eastern China, from April to July 2007. All participants
in this cross-sectional surv e yw e r ep e r m a n e n tl o c a l
residents aged more than 20 years old, and all had
signed informed consent documents. A total of 10,867
subjects completed an interview and physical examina-
tion and all of them were ethnic Han Chinese. We
selected as cases of IFG all subjects whose FPG was
between 5.6 mmol/l and 7.0 mmol/l (2004 ADA defini-
tion) after fasting more than 8 hours. Subjects who
self-reported a history of diabetes (7.40%) and other
chronic diseases (36.42%, e.g. hypertension, coronary
heart diseases, dyslipidaemia and stroke) were
excluded. Two healthy controls who did not report any
chronic diseases and had an FPG < 5.6 mmol/l were
randomly chosen from the database for each case,
matched on age (± 5 years), gender and resident dis-
trict, by using SAS matching MACRO. As a result, 648
IFG cases and 1296 age- and sex-matched controls
were available for the analyses.
All participants were interviewed by trained inter-
viewers using standard questionnaires to obtain infor-
mation on demographic data, smoking, alcohol drinking,
and family history of diabetes and CVDs in first-degree
relatives (parents, siblings and children). Height and
weight were measured to within 0.5 cm and 0.1 kg,
respectively. Body mass index (BMI) (kg/m
2) was used
as an indicator of overall adiposity. Waist circumference
(WC), a validated estimate of abdominal adiposity, was
measured to within 0.5 cm. Sitting blood pressure (sys-
tolic and fifth-phase diastolic) was recorded 3 times
with a standard mercury sphygmomanometer after a 15-
min rest.
A 5 ml blood sample was collected from each subject
after fasting more than 8 hours. The coagulated blood
was then centrifuged at 3,000 rpm for 10 min. The
serum was used to measure glucose levels and lipid
markers, including total cholesterol (TC), triglyceride
(TG), and high-density lipoprotein-cholesterol (HDL-C),
within 2 hours after blood collection. All the biochem-
ical markers were measured using an OLYMPUS
(C2734-Au640) automatic analyzer in the central labora-
tory of Wuxi Center for Disease Prevention and Con-
trol, which was authorized to perform laboratory tests
according to the international quality standard ISO/IEC
17025. The Beijing Institute of Geriatrics of Beijing Hos-
pital, Ministry of Health performed regular periodic
assessments of laboratory quality using quality control
samples.
IFG was defined according to the 2004 ADA definition
as FPG from 5.6 mmol/l to 7.0 mmol/l. The definition
of dyslipidaemias accorded with the criteria of the
“China Guidelines on Prevention and Management of
Dyslipidaemias in Chinese Adults.”[10] The borderline
high cholesterol level was 5.18-6.21 mmol/l, and subjects
were defined as having hypercholesterolemia if their TC
was ≥ 6.22 mmol/l. The borderline high triglyceride
level was 1.70-2.25 mmol/l, and subjects were defined as
having high triglyceride if their TG were ≥ 2.26 mmol/l.
Subjects were defined as having low HDL-C if their
HDL-C levels were < 1.04 mmol/l. BMI was calculated
as weight (kg)/height (m)
2, and subjects were considered
as normal weight if their BMI was < 24 kg/m
2,o v e r -
weight if their BMI was from 24 to 27.9 kg/m
2 and
obese if their BMI was ≥ 28 kg/m
2.S u b j e c t sw e r ec o n -
sidered as having central obesity if their WC was > 85
cm for men and > 80 cm for women [11]. Those whose
average systolic blood pressure (SBP) was ≥ 140 mmHg
and/or diastolic blood pressure (DBP) ≥ 90 mmHg were
defined as hypertensive, according to the WHO criteria.
We used SAS 9.1.3 (SAS Institute, Inc., Cary, NC) for
data management and analyses. Means and their stan-
dard deviations (SDs) were used for the continuous vari-
ables, and frequencies and percentages were used for
categorical variables in the analysis. Spearman correla-
tion analysis was used to estimate the relationships
among related variables. Odds ratios (ORs) and their
95% confidence intervals (95%CIs) from the multivariate
logistic regression models were used to evaluate associa-
tions between IFG and other risk factors, after adjusting
the available covariates such as education level, monthly
income and family history of diabetes. We also assessed
the joint dose-response effects of overweight, hyperten-
sion and dyslipidemia on the odds of IFG by defining as
abnormal a BMI ≥ 24 kg/m
2,aS B P≥ 140 mmHg and/
or DBP ≥ 90 mmHg, a TG ≥ 1.70 mmol/l, a HDL-C <
1.04 mmol/l, and a TC ≥ 5.18 mmol/l, and evaluated
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ities. All statistical tests were two-sided, and p-values ≤
0.05 were considered statistically significant.
Results
The total number of subjects included in this analysis
was 1944, of whom 648 were cases of IFG and 1296
were matched controls with normal blood glucose. Of
the 1944 subjects, 45.06% were males and 54.94% were
females. Their ages ranged from 21 years to 79 years.
The means and standard deviations (SDs) of age were
60.53 ± 11.39 years for IFG cases and 59.75 ± 11.29
years for controls, respectively. There were no statisti-
cally significant differences in age, gender, educational
level and individual monthly income between IFG sub-
jects and controls (Table 1). More IFG subjects
(10.56%) reported having family history of diabetes
than controls (6.45%) (p = 0.002, Table 1). As
expected, IFG subjects had significantly higher BMI,
WC, TC, TG, SBP and DBP, and lower HDL-C than
did controls, and these differences were seen in both
men and women. (Table 2)
In the bivariate Spearmen correlation analyses (Table
3), FPG was positively correlated with BMI, WC, SBP,
DBP, TG, TC, and negatively correlated with HDL-C.
The highest correlation coefficients (r) with FPG were
0.325 for BMI and 0.266 for WC. For the three lipid
markers, TG was more strongly correlated with FPG (r
= 0.244) than TC (r = 0.134) and HDL-C (r = -0.192).
In the logistic regression analyses, with adjustment for
education level, individual monthly income, family his-
tory of diabetes (Table 4), BMI was strongly associated
with increased risk of IFG in both men and women.
Overweight (24 kg/m
2 ≤ BMI < 28 kg/m
2) and obesity
(BMI ≥ 28 kg/m
2) were associated with a 2.32-fold (OR
= 2.32, 95%CI: 1.86-2.88) and a 4.63-fold (OR = 4.63,
95%CI: 3.36-6.37) higher risk of IFG, respectively, com-
pared with normal-weight subjects. The effect of obesity
(BMI ≥ 28 kg/m
2) was more evident in male subjects
(OR = 6.37, 95%CI: 3.76-10.79). Central obesity (WC ≥
85 cm in males and WC ≥ 80 cm in females) was asso-
ciated with a 2.74-fold elevated risk (OR = 2.74, 95%CI:
2.19-3.44) of IFG relative to those with normal WC. For
the lipid markers, both TC and TG were significantly
associated with IFG. Nevertheless, TG appeared to be
more strongly associated w i t hI F Gt h a nT Ci nt h i s
population. Compared to subjects with TG < 1.70
mmol/l, those with borderline high TG levels (1.70 to
2.26 mmol/l) and high TG (≥ 2.26 mmol/l) had a 1.76-
fold (95%CI: 1.31-2.36) and a 3.13-fold (95%CI: 2.50-
3.91) elevated risk of IFG, respectively. Compared to the
normal TC level group (TC < 5.18 mmol/l), the odds of
IFG were significantly higher in persons with higher TC
levels (OR = 1.32, 95%CI: 1.06-1.66 for those with 5.18
mmol/l ≤ TC < 6.22 mmol/l; and OR = 2.01, 95%CI:
1.42-2.84 for those with TC ≥ 6.22 mmol/l). Higher
HDL-C was significantly associated with a decreased
risk of IFG (OR = 0.43, 95%CI: 0.34-0.56). In addition,
hypertension was associated with a 2.68-fold (95%CI:
2.19-3.29) increased odds of IFG compared to those
with normal blood pressure.
We also assessed the joint effects of overweight (BMI
≥ 24 kg/m
2), hypertension (SBP ≥ 140 mmHg and/or
DBP ≥ 90 mmHg) and dyslipidemia (TG ≥ 1.70 mmol/l,
HDL-C < 1.04 mmol/l and/or TC ≥ 5.18 mmol/l) on
the odds of IFG. We evaluated the risk of IFG associated
with the number of above 5 abnormalities. There was a
significant dose-response relationship between an
increased number of abnormalities and the odds of IFG
(p for trend < 0.001). Subjects having 1, 2, 3, 4 and 5
abnormal items had 1.63 (95%CI: 1.08-2.46), 2.91 (95%
CI: 1.98-4.28), 6.44 (95%CI: 4.37-9.49), 9.51 (95%CI:
6.13-14.73) and 22.49 (95%CI: 7.03-71.96) times higher
odds of IFG compared to those without abnormalities,
respectively (Figure 1).
Table 1 Social-demographic characteristics of IFG
subjects and controls in a Chinese population
Variables IFG
(n = 648)
No. (%)
controls
(n = 1296)
No. (%)
p
value
Gender 1.000
Male 292 (45.06) 584 (45.06)
Female 356 (54.94) 712 (54.94)
Age (years) (mean ± SD) 60.53 ±
11.39
59.75 ±
11.29
0.151
Age (years) 0.253
<45 54 (8.34) 122 (9.41)
45~60 232 (35.80) 501 (38.66)
≥ 60 362 (55.86) 673 (51.93)
Education level 0.051
Illiteracy or primary school 190 (29.32) 333 (25.70)
Middle and high school 354 (55.05) 704 (54.62)
College and higher 104 (16.05) 259 (20.09)
Individual monthly income (RMB)
*
0.090
< 1000 300 (49.42) 532 (44.22)
1000~2000 280 (46.13) 603 (50.13)
≥ 2000 27 (4.45) 68 (5.65)
Family history of diabetes** 0.002
No 576 (89.44) 1203 (93.55)
Yes 68 (10.56) 83 (6.45)
* 134 subjects (41 cases and 93 controls) did not provide the individual
monthly income information
** 14 subjects (4 cases and 10 controls) did not provide the family history of
diabetes information
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consideration, we found that subjects with both abnor-
mal BMI (≥ 24 kg/m
2)a n dW C( ≥ 85 cm for men and
≥ 80 cm for women) had a statistically significant 4.06-
fold (95%CI: 3.12-5.28) elevated odds for IFG, almost
double that of subjects with only one abnormal variable
(OR = 2.09, 95%CI: 1.54-2.85) for abnormal WC and
OR = 2.59, 95%CI: 1.61-4.17 for higher BMI, respec-
tively) (Table 5). These associations were similar for
both men and women. For the combination of TG and
TC, subjects with both abnormal TG (≥ 1.70 mmol/l)
and TC (≥ 5.18 mmol/l) had an odds ratio of 3.03 (95%
CI: 2.31-3.97), while those with elevated TG alone had
an OR of 2.97 (95%CI: 2.28-3.85), and those with ele-
vated TC alone had an OR of 1.63 (95%CI: 1.13-2.35),
indicating that TG was the more important contributor
to the association (Table 5).
Discussion
In this community-based, case-control study of impaired
fasting glucose in a Chinese population, we confirmed
previous reports of significant associations between fast-
ing plasma glucose and body mass index, waist circum-
ference, total cholesterol, triglycerides, systolic and
diastolic blood pressure, and HDL-cholesterol. Levels of
BMI, WC, TG, TC, SBP and DBP were significantly
higher in cases with IFG than in normoglycemic controls,
whereas the level of HDL-C was significantly lower in
both men and women with IFG. Both BMI and WC were
significantly related to FPG, TG, TC, HDL-C, SBP and
Table 2 Comparison of the levels of BMI, WC, BP and lipids between IFG subjects and controls
Variables Overall Men Women
IFG
(n = 648)
Control (n = 1296) IFG
(n = 292)
Control
(n = 584)
IFG
(n = 356)
Control
(n = 712)
BMI(kg/m
2) 25.34 ± 3.44 23.21 ± 3.11** 25.32 ± 3.15 23.27 ± 2.94** 25.36 ± 3.67 23.16 ± 3.25**
WC(cm) 89.21 ± 10.10 83.92 ± 9.92** 90.93 ± 9.72 85.76 ± 9.14** 87.82 ± 10.20 82.42 ± 10.28**
TG(mmol/l) 2.98 ± 2.55 2.05 ± 1.69** 2.98 ± 2.61 2.06 ± 1.77** 3.00 ± 2.49 2.05 ± 1.62**
HDL-C(mmol/l) 1.28 ± 0.31 1.41 ± 0.37** 1.22 ± 0.30 1.32 ± 0.34** 1.33 ± 0.32 1.49 ± 0.38**
T C (mmol/l) 5.06 ± 1.09 4.84 ± 0.93** 4.93 ± 1.05 4.66 ± 0.85** 5.16 ± 1.11 4.99 ± 0.98*
SBP(mmHg) 134.22 ± 19.05 126.07 ± 17.26** 130.07 ± 19.85 128.22 ± 17.50** 132.70 ± 18.25 124.32 ± 16.88**
DBP(mmHg) 83.20 ± 10.23 79.31 ± 9.43** 84.73 ± 10.61 81.05 ± 9.54** 81.95 ± 9.74 77.89 ± 9.10**
*p < 0.05; ** p < 0.01
Table 3 Spearman correlation analysis of selected variables in both IFG subjects and controls (n = 1944)
r WC SBP DBP TG HDL-C TC FPG
BMI overall 0.701** 0.218** 0.248** 0.248** -0.298** 0.083** 0.325**
men 0.710** 0.214* 0.252** 0.267** -0.322** 0.123** 0.340**
women 0.707** 0.223** 0.249** 0.176** -0.290** 0.060 0.315**
WC overall 0.267** 0.251** 0.209** -0.282** 0.095** 0.266**
men 0.243** 0.240** 0.252** -0.244** 0.178** 0.288**
women 0.266** 0.227** 0.180** -0.266** 0.084** 0.262**
SBP overall 0.711** 0.128** -0.068** 0.099** 0.248**
men 0.738** 0.084* 0.056 0.075* 0.225**
women 0.678** 0.170** -0.129** 0.147** 0.276**
DBP overall 0.157** -0.117** 0.084** 0.214**
men 0.155** -0.023 0.097** 0.200**
women 0.162** -0.138** 0.120** 0.236**
TG overall -0.431** 0.300** 0.244**
men -0.413** 0.328** 0.218**
women -0.464** 0.285** 0.268**
HDL-C overall 0.249** -0.192**
men 0.191** -0.145**
women 0.247** -0.244**
TC overall 0.134**
men 0.143**
women 0.124**
*p < 0.05; ** p < 0.01
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than that for WC and FPG. TG was more strongly corre-
lated with FPG than TC and HDL-C. The odds of IFG
increased with the numbers of abnormal variables.
Our finding of significantly positive relationships
between IFG and BMI and WC are consistent with
reports from other studies in different populations
[ 1 2 , 1 3 ]a n di n d i c a t et h a to v e r w e i g h ta n do b e s i t yc o u l d
result in higher insulin concentration, secretion and
resistance [14]. Hu et al., found that central obesity was
more related to IFG than overall obesity in a northern
Chinese population [15]. However, in our study BMI was
more strongly related to FPG than WC, as indicated by
the higher correlation coefficient, and we found that sub-
jects with both central obesity and overall obesity had a
doubled odds of IFG compared to those with only one of
these abnormalities. This finding suggests that both BMI
and WC should be taken into consideration as obesity
indicators that predict IFG in the Chinese population,
and they should be considered simultaneously as targets
for possible interventions to prevent IFG.
Table 4 Associations between BMI, WC, blood lipids, BP and risk of IFG
Variables IFG(%)
(n = 648)
Control(%)
(n = 1296)
Adjusted-OR*
(95%CI)(overall)
Adjusted-OR* (95%CI)(men) Adjusted-OR*
(95%CI)(women)
BMI (kg/m
2)
BMI < 24 233 (35.95) 793 (61.19) 1.00 1.00 1.00
24 ≤ BMI < 28 286 (44.14) 413 (31.87) 2.32 (1.86-2.88) 2.23 (1.61-3.09) 2.43 (1.79-3.28)
BM I ≥ 28 129 (19.91) 90 (6.94) 4.63 (3.36-6.37) 6.37 (3.76-10.79) 3.98 (2.64-6.00)
WC (cm)
WC < 85 (male)
WC < 80 (female)
140 (21.60) 562 (43.36) 1.00 1.00 1.00
WC ≥ 85 (male)
WC ≥ 80 (female)
508 (78.40) 734 (56.64) 2.74 (2.19-3.44) 2.57 (1.85-3.56) 3.00 (2.18-4.13)
TC (mmol/l)
TC < 5.18 382 (58.95) 878 (67.75) 1.00 1.00 1.00
5.18 ≤ TC < 6.22 192 (29.63) 329 (25.39) 1.32 (1.06-1.66) 1.53 (1.08-2.17) 1.22 (0.90-1.64)
TC ≥ 6.22 74 (11.42) 89 (6.86) 2.01 (1.42-2.84) 2.47 (1.34-4.57) 1.86 (1.21-2.84)
TG (mmol/l)
TG < 1.70 203 (31.33) 696 (53.70) 1.00 1.00 1.00
1.70 ≤ TG < 2.26 107 (16.51) 213 (16.44) 1.76 (1.31-2.36) 2.18 (1.40-3.40) 1.51 (1.02-2.25)
TG ≥ 2.26 338 (52.16) 387 (29.86) 3.13 (2.50-3.91) 3.09 (2.20-4.33) 3.26 (2.40-4.43)
HDL-C (mmol/l)
HDL-C < 1.04 153 (23.61) 160 (12.35) 1.00 1.00 1.00
HDL-C ≥ 1.04 495 (76.39) 1136 (87.65) 0.43 (0.34-0.56) 0.44 (0.31-0.63) 0.42 (0.29-0.62)
BP (mmHg)
SBP < 140 and DBP < 90 308 (47.53) 901 (69.52) 1.00 1.00 1.00
SBP ≥ 140 and/or DBP ≥ 90 340 (52.47) 395 (30.48) 2.68 (2.19-3.29) 2.32 (1.71-3.14) 3.05 (2.30-4.04)
* adjusted for education level, individual monthly income, family history of diabetes.
1.00 
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Figure 1 Combined effect of 5 abnormal variables on the risk
of IFG. (5 abnormal variables include BMI ≥ 24 kg/m
2, SBP ≥ 140
mmHg and/or DBP ≥ 90 mmHg, TG ≥ 1.70 mmol/l, HDL-C < 1.04
mmol/l, and TC ≥ 5.18 mmol/l) (* adjusted for education level,
monthly income and family history of diabetes).
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study indicated that TG and TC levels were positively
correlated with FPG and that HDL-C was negatively
correlated with FPG in both male and female popula-
tions. The dysregulation of lipid and lipoprotein in the
hyperglycaemic state may be a manifestation of underly-
ing insulin resistance, which is a central pathophysiolo-
gical feature of type 2 diabetes and abdominal obesity.
Insulin resistance results in hyperinsulinemia, enhanced
hepatic gluconeogenesis and glucose output. It also
reduces suppression of lipolysis in adipose tissue, lead-
ing to high free acid flux, and it increases hepatic very
low density lipoprotein secretion leading to hypertrigly-
ceridemia and reduced levels of HDL-C [18]. However,
many studies have shown that dysregulation of fatty
acid metabolism plays the key role in the etiology of
IFG [19,20]. An important observation from the San
Antonio Heart Study was that several independent pre-
dictors of diabetes that were present before the onset of
hyperglycaemia were correlated with each other, includ-
ing elevated BMI and insulin levels, hypertriglyceridae-
mia, hypertension and lower HDL-C [21]. Obesity was
also one of the most important factors associated with
serum lipid profiles in our study, in which both BMI
and WC were positively correlated with TG and TC and
negatively correlated with HDL-C. These factors of obe-
sity and abnormal lipids might work together and rein-
force the development of IFG. Our study results also
suggest that TG may be more strongly correlated with
IFG than TC and HDL-C. Love-Osborne and colleagues
reported that elevated fasting triglycerides could predict
risk of impaired glucose tolerance [22]. TG, as a lipid
marker, also can be used as one of the most important
predictors of IFG.
There was also a significant association between high
blood pressure and increased blood glucose in our
study. The association between hypertension and IFG
can probably be related to the metabolic syndrome [23],
and a modest association between hyperinsulinaemia
and hypertension has been reported previously [24]. In a
cohort of 63,443 consecutive men, Patrick, et al.,
demonstrated that risk ratios for 8-year cardiovascular
disease mortality and total mortality were significantly
higher in the IFG subjects with 140 ≤ SBP ≤ 159 mmHg
compared to those with normal fasting glucose [25].
The close relationship between insulin resistance and
hypertension may be because of their similar molecular
mechanisms [26,27].
All the risk factors in our study, including overweight
(obesity), dyslipidaemias and hypertension are compo-
nents of the metabolic syndrome and insulin resistance.
The World Health Organization (WHO) working defini-
tion of metabolic syndrome includes a raised plasma TG
and/or low HDL-C, central obesity and/or high BMI
ratio, measurement of impaired glucose regulation or/
and insulin resistance, arterial hypertension and microal-
buminuria [28]. In the present study of this Chinese
population, we found that elevated TG, both central
(WC) and overall obesity (BMI), and hypertension were
important predictors of IFG, which is a key representa-
tion of the metabolic syndrome [29]. Rapid economic
development and changing lifestyles in the Chinese
population in the past three decades have resulted in a
steady increase in the prevalence of obesity [30]. The
strong association between overweight and IFG empha-
sizes the importance of weight control interventions to
reduce the prevalence of IFG in the population. Identify-
ing and reducing these factors, including BMI, WC, TG,
and BP, as well as FPG, may improve the health of the
general population of China, and more programs should
be targeted towards control of IFG and related public
health problems.
Several limitations of this study need to be addressed.
Firstly, this is a cross-sectional investigation and it is
really difficult to determine which is the risk factor and
which is the outcome in terms of the variables included
Table 5 Combined effects of BMI and WC, TG and TG associated with IFG
Combined variables IFG(%)
(n = 648)
Control(%)
(n = 1296)
Adjusted-OR*
(95%CI)(overall)
Adjusted-OR*
(95%CI)(men)
Adjusted-OR*
(95%CI)(women)
BMI and WC
BMI < 24 and WC < 85(men) 80(women) 106 (16.36) 488 (37.65) 1.00 1.00 1.00
BMI < 24 and WC ≥ 85(men) 80(women) 127 (19.60) 305 (23.53) 2.09 (1.54-2.85) 1.83 (1.14-2.95) 2.39 (1.59-3.61)
BMI ≥ 24 and WC < 85(men) 80(women) 34 (5.24) 74 (5.71) 2.59 (1.61-4.17) 2.26 (1.19-4.29) 3.00 (1.48-6.11)
BMI ≥ 24 and WC ≥ 85(men) 80(women) 381 (58.80) 429 (33.10) 4.06 (3.12-5.28) 3.72 (2.54-5.44) 4.54 (3.13-6.57)
TG and TC
TG < 1.70 and TC < 5.18 143 (22.07) 550 (42.44) 1.00 1.00 1.00
TG < 1.70 and TC ≥ 5.18 60 (9.26) 146 (11.26) 1.63 (1.13-2.35) 2.82 (1.56-5.08) 1.22 (0.75-1.97)
TG ≥ 1.70 and TC < 5.18 239 (36.88) 328 (25.31) 2.97 (2.28-3.85) 3.50 (2.39-5.12) 2.62 (1.82-3.77)
TG ≥ 1.70 and TC ≥ 5.18 206 (31.79) 272 (20.99) 3.03 (2.31-3.97) 3.39 (2.22-5.18) 2.84 (1.96-4.08)
* adjusted for education level, individual monthly income, family history of diabetes.
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Page 6 of 8in this study. Secondly, all of our IFG cases were from
one community of Wuxi city, a rapidly developed area
in eastern China, which may not represent for those of
other places. Large multi-center prospective follow-up
studies or intervention studies are warranted to further
evaluate the public health meanings of these risk factors.
Conclusions
In this Chinese population, both BMI and WC were
important predictors of IFG. Abnormal TG as a lipid
marker was more strongly associated with IFG than
were TC and HDL-C. These factors should be taken
into consideration simultaneously for prevention of
IFG.
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